<DOC>
	<DOCNO>NCT02088515</DOCNO>
	<brief_summary>The treatment squamous cell carcinoma lung improve suffuciently . Nedaplatin second-generation platinum compound active squamous cell carcinoma lung response rate 60 % , issue finish Phase II trial Japan .</brief_summary>
	<brief_title>Nedaplatin ( Jiebaishu® ) Combined With Docetaxel Advanced Lung Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1. primary lung squamous carcinoma confirm cytology histology , exclude sputum examination . 2 . IIIBno radiotherapy indication /IV phase ASLC 2009 TNM criterion . 3. least one measurable tumor base RECIST ( long diameter : ≥20 mm CT scan 10 mm spiral CT ) 4. male female , age≥18 ≤75 year old 5 . ECOG PS : 0 1 6. estimated time survival : ≥12 week 7. suitable hematologic function : ANC≥2×109/L , PLC≥100×109/L Hb≥9 g/dL 8. suitable liver function : Total bilirubin≤normal ULN , AST ALT≤2.5×normal ULN , ALP≤5×normal ULN . 9. suitable renal function : Cr≤normal ULN , Ccr≥60 ml/min 10. history chemotherapy 11. enrollment , past operation 4 week subject recover . 12. female subject intact uterus , amenorrhea less 24 month , pregnancy test must negative within 28 day enrollment . If pregnancy test past 7 day time initial chemotherapy , urine pregnancy test must do . 13. authorized ICF must sign 1. cancer recent five year , cure skin basal cell carcinoma cervical carcinoma exclude . 2. evidence CNS metastasis , matter treat ; suspicious CNS metastasis , CNS MRI enhance CT scan must do within 28 day enrollment . 3 . AST /or ALT＞2.5×normal ULN , ALP＞5×normal ULN . 4. radiotherapy past ( exclude palliative radiotherapy pain relief measurable tumor outside radio field ) 5. chemotherapy past ( exclude bisphosphonates ) 6. uncontrolled disease . 7. female pregnancy feed . 8. subject productivity capacity , refusal use effective contraception measure . 9. participate clinical trial time treatment period . 10. allergy test drug 11. uncontrolled disease 12 . BMT do .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Nedaplatin</keyword>
	<keyword>lung squamous cell carcinoma</keyword>
</DOC>